Officials are moving behind the scenes to head off a conflict brewing between states and the federal government over ...
In this week's "STATus Report," STAT reporters break down how the midterms could shape federal health and science policy, and ...
An 1834 letter about a measles outbreak sheds light on today’s anti-vaccine movement, writes a medical historian.
The task force is a critical advisory body to HHS, reviewing scientific evidence to provide recommendations on whether ...
Sayed, the Democratic Senate candidate in Michigan, pushes back against the RFK Jr.'s claims, and the new FDA policy around ...
Among them, Florida Surgeon General Joseph Ladapo, who made inaccurate claims about the hepatitis B vaccine; Michael Boes, ...
WASHINGTON — Ever since the Treasury Department proposed to limit U.S. investment in the Chinese biotech industry last week, ...
The Trump administration is giving the peptide craze a regulatory boost, despite objections from FDA career scientists.
There’s reason to think that overdependence on AI could make us less capable as researchers. Then there are potential job ...
The fallout has become especially pronounced under President Trump. That’s in part because the expiration of Affordable Care ...
A judge ruled that federal regulators exceeded their authority in narrowing the exceptions to Medicaid work requirements for ...
Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results